Rashmi Khanal

569 total citations
15 papers, 42 citations indexed

About

Rashmi Khanal is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Rashmi Khanal has authored 15 papers receiving a total of 42 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 4 papers in Pathology and Forensic Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Rashmi Khanal's work include CAR-T cell therapy research (6 papers), Lymphoma Diagnosis and Treatment (3 papers) and Neutropenia and Cancer Infections (2 papers). Rashmi Khanal is often cited by papers focused on CAR-T cell therapy research (6 papers), Lymphoma Diagnosis and Treatment (3 papers) and Neutropenia and Cancer Infections (2 papers). Rashmi Khanal collaborates with scholars based in United States and India. Rashmi Khanal's co-authors include Crystal S. Denlinger, Aakanksha Sharma, Neelesh Sharma, Prantesh Jain, Yan Feng, Michael Styler, Henry C. Fung, Mili Mandal, Michael Emig and Peter Flynn and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Rashmi Khanal

10 papers receiving 41 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rashmi Khanal United States 4 23 16 12 8 8 15 42
Sara Arce‐Gallego Spain 3 17 0.7× 26 1.6× 14 1.2× 5 0.6× 3 0.4× 5 43
Massimo Di Gioia Italy 3 17 0.7× 30 1.9× 5 0.4× 10 1.3× 6 0.8× 6 49
Seonggon Kim South Korea 5 9 0.4× 39 2.4× 11 0.9× 5 0.6× 10 1.3× 8 65
Matthew R. Hart United States 5 25 1.1× 24 1.5× 9 0.8× 4 0.5× 13 1.6× 5 61
Johan Verschuere Belgium 4 13 0.6× 18 1.1× 19 1.6× 7 0.9× 4 0.5× 6 53
Jesus D. Anampa United States 5 21 0.9× 7 0.4× 13 1.1× 8 1.0× 2 0.3× 11 43
Reanne Bowlby Canada 4 24 1.0× 28 1.8× 11 0.9× 7 0.9× 2 0.3× 7 69
Abigail Washington United States 4 12 0.5× 28 1.8× 10 0.8× 4 0.5× 16 2.0× 12 51
Christina Geörg Germany 3 14 0.6× 29 1.8× 21 1.8× 12 1.5× 3 0.4× 3 59
Alicia Beeghly‐Fadiel United States 2 17 0.7× 23 1.4× 6 0.5× 5 0.6× 3 0.4× 2 54

Countries citing papers authored by Rashmi Khanal

Since Specialization
Citations

This map shows the geographic impact of Rashmi Khanal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rashmi Khanal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rashmi Khanal more than expected).

Fields of papers citing papers by Rashmi Khanal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rashmi Khanal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rashmi Khanal. The network helps show where Rashmi Khanal may publish in the future.

Co-authorship network of co-authors of Rashmi Khanal

This figure shows the co-authorship network connecting the top 25 collaborators of Rashmi Khanal. A scholar is included among the top collaborators of Rashmi Khanal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rashmi Khanal. Rashmi Khanal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Matasar, Matthew J., Marcus Messmer, Rashmi Khanal, et al.. (2024). Abstract CT245: Circulating tumor DNA and nivolumab maintenance: A pilot study in diffuse large B cell lymphoma. Cancer Research. 84(7_Supplement). CT245–CT245.
3.
4.
Vartanov, Alexander R., Michele Sorrentino, Anne Ojala, et al.. (2024). Using Oral Vancomycin As Prophylaxis Against Clostridioides Difficile Infection in Stem Cell Transplant Recipients Is Associated with Increased Gram Negative Bacteremia. Transplantation and Cellular Therapy. 30(2). S440–S440.
5.
Khanal, Rashmi, et al.. (2024). FLAG/IDA/Venetoclax Induction in Patients with FLT3+ Acute Myeloid Leukemia. Blood. 144(Supplement 1). 6028–6028.
6.
Khanal, Rashmi, et al.. (2024). Gaps in Long Term Follow up Assessment of Lymphoma Patients Following Autologous Hematopoietic Stem Cell Transplant. Transplantation and Cellular Therapy. 30(2). S443–S444. 1 indexed citations
7.
Styler, Michael, et al.. (2023). MM-595 Feasibility and Safety of Outpatient Model for Teclistamab Step-Up Dosing Administration: A Single Center Experience. Clinical Lymphoma Myeloma & Leukemia. 23. S509–S509. 2 indexed citations
8.
Khanal, Rashmi, Amitkumar Mehta, Joseph Maly, et al.. (2023). AB-101, an allogeneic, non–genetically modified, natural killer (NK) cell therapy, evaluated as monotherapy or in combination with rituximab in R/R non-Hodgkin lymphoma.. Journal of Clinical Oncology. 41(16_suppl). 7529–7529. 3 indexed citations
9.
Styler, Michael, et al.. (2023). P940: AN OUTPATIENT MODEL FOR TECLISTAMAB STEP-UP DOSING ADMINISTRATION – INITIAL EXPERIENCES AT FOX CHASE CANCER CENTER BMT PROGRAM.. HemaSphere. 7(S3). e605007f–e605007f. 5 indexed citations
10.
Sorrentino, Michele, et al.. (2023). Safety and Efficacy of Oral Vancomycin Prophylaxis Against Clostridioides Difficile Infection in Stem Cell Transplant Recipients. Transplantation and Cellular Therapy. 29(2). S114–S115. 1 indexed citations
11.
12.
Khanal, Rashmi, et al.. (2020). Oxaliplatin-induced Immune Thrombocytopenia: A Case Report and Literature Review. Clinical Colorectal Cancer. 20(1). e1–e4. 11 indexed citations
13.
Gupta, Ridhi, et al.. (2016). Fosaprepitant as a risk factor for ifosfamide induced encephalopathy: A single institution experience.. Journal of Clinical Oncology. 34(15_suppl). e14104–e14104. 2 indexed citations
14.
Jain, Prantesh, Rashmi Khanal, Aakanksha Sharma, Yan Feng, & Neelesh Sharma. (2014). Afatinib and lung cancer. Expert Review of Anticancer Therapy. 14(12). 1391–1406. 14 indexed citations
15.
Khanal, Rashmi, Tarun Sharma, & Fahad Aziz. (2011). Hashimoto's disease presenting as cardiac tamponade.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sara Arce‐Gallego Breakdown of academic impact, for papers by Massimo Di Gioia Breakdown of academic impact, for papers by Seonggon Kim Breakdown of academic impact, for papers by Matthew R. Hart Breakdown of academic impact, for papers by Johan Verschuere Breakdown of academic impact, for papers by Jesus D. Anampa Breakdown of academic impact, for papers by Reanne Bowlby Breakdown of academic impact, for papers by Abigail Washington Breakdown of academic impact, for papers by Christina Geörg Breakdown of academic impact, for papers by Alicia Beeghly‐Fadiel
Rankless by CCL
2026